WebApr 12, 2024 · 3 brokerages have issued 12-month price objectives for Cullinan Oncology's shares. Their CGEM share price forecasts range from $19.00 to $50.00. On average, they predict the company's share price to reach $34.50 in the next twelve months. This suggests a possible upside of 243.3% from the stock's current price. WebJan 4, 2024 · Cullinan Oncology, LLC, a Cambridge, MA-based company, plans to raise about $150 million by offering 8.3 million shares at a price range of $17 to $19. At the midpoint of this range, Cullinan’s market value would be $750 million, fully diluted. The company is focused on developing a diversified pipeline of targeted oncology and …
Cullinan Oncology - Overview, News & Competitors ZoomInfo.com
WebJan 8, 2024 · CAMBRIDGE, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Cullinan Management, Inc. Cullinan Management. Morgan Stanley & Co. LLC, SVB Leerink LLC, and Evercore Group LLC are acting as joint book ... WebCAMBRIDGE, Mass., June 4, 2024 – – Cullinan Oncology, LLC announced today the closing of a $98.5 million Series B financing, which will be used to support ongoing clinical trials across its small molecule and biologics portfolio. New institutional investors and family offices participated in the financing alongside original commitments from ... dutch blue lovebird
Search and Evaluation - Cullinan Oncology - LinkedIn
WebJun 2, 2024 · DOI: 10.1200/JCO.2024.40.16_suppl.9007 Journal of Clinical Oncology - published online before print June 2, 2024 Phase (Ph) 1/2a study of CLN-081 in patients (pts) with NSCLC with EGFR exon 20 insertion mutations (Ins20). ... Cullinan Oncology, LLC. OPTIONS & TOOLS. Export Citation: Track Citation: Add To Favorites: Rights & … WebDec 28, 2024 · CULLINAN ONCOLOGY CONTACTS: Investors: Jeff Trigilio +1 716.725.5019 [email protected]. Media: Matt Burke +1 603.315.0618 … Web在经历了跌宕起伏的2024年后,2 023 年第一季度末,创新药企迎来年终财报考核。. 在这个充满挑战的一年,“内卷”“活着”等词汇成为创新药领域的关键词。不过对于和铂医药而言,2024年则是充满机遇的一年。 dutch blue lovebird images